Skip to main content
Top

Open Access 02-02-2024 | Research

Exact-matching algorithms using administrative health claims database equivalence factors for real-world data analysis based on the target trial emulation framework

Authors: Yuichi Nishioka, Emiri Morita, Saki Takeshita, Sakura Tamamoto, Tomoya Myojin, Tatsuya Noda, Tomoaki Imamura

Published in: Health Services and Outcomes Research Methodology

Login to get access

Abstract

Real-world data have become increasingly important in medical science and healthcare. A new, effective, and practically feasible statistical design is needed to unlock the potential of real-world data that decision-makers and practitioners can use to meet people’s healthcare needs. In the first half of the study, we validated our proposed new method by simulation, and in the second half, we conducted a clinical study on actual real-world data. We proposed the “Exact Matching Algorithm Using Administrative Health Claims Database Equivalence Factors (AHCDEFs)” using a target trial emulation framework. The simulation trials were conducted 500 times independently, considering the misclassification and chance errors of all variables and competing events of outcome. Two conventional methods, multivariate and propensity score analyses, were compared. Next, we estimated the effect of specific health guidance provided in Japan on the prevention of diabetes onset and medical expenditures. Our proposed novel method for real-world data returns improved estimates and fewer type I errors (the probability of erroneously determining that there is a difference when, in fact, there is no difference) than conventional methods. We quantitatively demonstrated the effectiveness of specific health guidance in Japan in preventing the onset of diabetes and reducing medical expenditures during five years. We proposed a new method for analyzing real-world data and an exact-matching algorithm using AHCDEFs. The larger the number of patients available for analysis, the more the AHCDEFs that can be matched, thereby removing the influence of confounding factors. This method will generate significant evidence when applied to real-world data.
Appendix
Available only for authorised users
Literature
go back to reference Baumfeld Andre, E., Reynolds, R., Caubel, P., Azoulay, L., Dreyer, N.A.: Trial designs using real-world data: The changing landscape of the regulatory approval process. Pharmacoepidemiol. Drug Saf. 29, 1201–1212 (2020)CrossRefPubMed Baumfeld Andre, E., Reynolds, R., Caubel, P., Azoulay, L., Dreyer, N.A.: Trial designs using real-world data: The changing landscape of the regulatory approval process. Pharmacoepidemiol. Drug Saf. 29, 1201–1212 (2020)CrossRefPubMed
go back to reference Frieden, T.R.: Evidence for health decision making - Beyond randomized, controlled trials. N. Engl. J. Med. 377, 465–475 (2017)CrossRefPubMed Frieden, T.R.: Evidence for health decision making - Beyond randomized, controlled trials. N. Engl. J. Med. 377, 465–475 (2017)CrossRefPubMed
go back to reference Fukuma, S., Iizuka, T., Ikenoue, T., Tsugawa, Y.: Association of the national health guidance intervention for obesity and cardiovascular risks with health outcomes among Japanese men. JAMA Intern. Med. 180, 1630–1637 (2020)CrossRefPubMedPubMedCentral Fukuma, S., Iizuka, T., Ikenoue, T., Tsugawa, Y.: Association of the national health guidance intervention for obesity and cardiovascular risks with health outcomes among Japanese men. JAMA Intern. Med. 180, 1630–1637 (2020)CrossRefPubMedPubMedCentral
go back to reference Hernán, M.A., Robins, J.M.: Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758–764 (2016)CrossRefPubMedPubMedCentral Hernán, M.A., Robins, J.M.: Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758–764 (2016)CrossRefPubMedPubMedCentral
go back to reference Hoffman, K.L., Schenck, E.J., Satlin, M.J., Whalen, W., Pan, D., Williams, N., Díaz, I.: Comparison of a target trial emulation framework vs cox regression to estimate the association of corticosteroids with COVID-19 mortality. JAMA Netw. Open 5, e2234425 (2022)CrossRefPubMedPubMedCentral Hoffman, K.L., Schenck, E.J., Satlin, M.J., Whalen, W., Pan, D., Williams, N., Díaz, I.: Comparison of a target trial emulation framework vs cox regression to estimate the association of corticosteroids with COVID-19 mortality. JAMA Netw. Open 5, e2234425 (2022)CrossRefPubMedPubMedCentral
go back to reference Madenci, A.L., Wanis, K.N., Cooper, Z., Haneuse, S., Subramanian, S.V., Hofman, A., Hernán, M.A.: Strengthening health services research using target trial emulation: An application to volume-outcomes studies. Am. J. Epidemiol. 190, 2453–2460 (2021)CrossRefPubMedPubMedCentral Madenci, A.L., Wanis, K.N., Cooper, Z., Haneuse, S., Subramanian, S.V., Hofman, A., Hernán, M.A.: Strengthening health services research using target trial emulation: An application to volume-outcomes studies. Am. J. Epidemiol. 190, 2453–2460 (2021)CrossRefPubMedPubMedCentral
go back to reference Matthews, A.A., Danaei, G., Islam, N., Kurth, T.: Target trial emulation: applying principles of randomised trials to observational studies. BMJ 378, e071108 (2022)CrossRefPubMed Matthews, A.A., Danaei, G., Islam, N., Kurth, T.: Target trial emulation: applying principles of randomised trials to observational studies. BMJ 378, e071108 (2022)CrossRefPubMed
go back to reference Mellinghoff, S.C., Bruns, C., Al-Monajjed, R., Cornely, F.B., Grosheva, M., Hampl, J.A., et al.: Harmonized procedure coding system for surgical procedures and analysis of surgical site infections (SSI) of five European countries. BMC Med. Res. Methodol. 22, 225 (2022)CrossRefPubMedPubMedCentral Mellinghoff, S.C., Bruns, C., Al-Monajjed, R., Cornely, F.B., Grosheva, M., Hampl, J.A., et al.: Harmonized procedure coding system for surgical procedures and analysis of surgical site infections (SSI) of five European countries. BMC Med. Res. Methodol. 22, 225 (2022)CrossRefPubMedPubMedCentral
go back to reference Muramoto, A., Matsushita, M., Kato, A., Yamamoto, N., Koike, G., Nakamura, M., et al.: Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan. Obes. Res. Clin. Pract. 8, e466–e475 (2014)CrossRefPubMed Muramoto, A., Matsushita, M., Kato, A., Yamamoto, N., Koike, G., Nakamura, M., et al.: Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan. Obes. Res. Clin. Pract. 8, e466–e475 (2014)CrossRefPubMed
go back to reference Nishioka, Y., Takeshita, S., Kubo, S., Myojin, T., Noda, T., Okada, S., et al.: Appropriate definition of diabetes using an administrative database: a cross-sectional cohort validation study. J. Diabetes Investig. 13, 249–255 (2022)CrossRefPubMed Nishioka, Y., Takeshita, S., Kubo, S., Myojin, T., Noda, T., Okada, S., et al.: Appropriate definition of diabetes using an administrative database: a cross-sectional cohort validation study. J. Diabetes Investig. 13, 249–255 (2022)CrossRefPubMed
go back to reference Rubin, D.B.: Using multivariate matched sampling and regression adjustment to control bias in observational studies. J. Am. Stat. Assoc. 74, 318–328 (1979) Rubin, D.B.: Using multivariate matched sampling and regression adjustment to control bias in observational studies. J. Am. Stat. Assoc. 74, 318–328 (1979)
go back to reference Schneeweiss, S., Rassen, J.A., Glynn, R.J., Avorn, J., Mogun, H., Brookhart, M.A.: High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology 20, 512–522 (2009)CrossRefPubMedPubMedCentral Schneeweiss, S., Rassen, J.A., Glynn, R.J., Avorn, J., Mogun, H., Brookhart, M.A.: High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology 20, 512–522 (2009)CrossRefPubMedPubMedCentral
go back to reference Seeger, J.D., Williams, P.L., Walker, A.M.: An application of propensity score matching using claims data. Pharmacoepidemiol. Drug Saf. 14, 465–476 (2005)CrossRefPubMed Seeger, J.D., Williams, P.L., Walker, A.M.: An application of propensity score matching using claims data. Pharmacoepidemiol. Drug Saf. 14, 465–476 (2005)CrossRefPubMed
go back to reference Takeuchi, Y., Kumamaru, H., Hagiwara, Y., Matsui, H., Yasunaga, H., Miyata, H., Matsuyama, Y.: Sodium-glucose cotransporter-2 inhibitors and the risk of urinary tract infection among diabetic patients in Japan: Target trial emulation using a nationwide administrative claims database. Diabetes Obes. Metab. 23, 1379–1388 (2021)CrossRefPubMed Takeuchi, Y., Kumamaru, H., Hagiwara, Y., Matsui, H., Yasunaga, H., Miyata, H., Matsuyama, Y.: Sodium-glucose cotransporter-2 inhibitors and the risk of urinary tract infection among diabetic patients in Japan: Target trial emulation using a nationwide administrative claims database. Diabetes Obes. Metab. 23, 1379–1388 (2021)CrossRefPubMed
go back to reference Tsushita, K., Hosler, A.S., Miura, K., Ito, Y., Fukuda, T., Kitamura, A., et al.: Rationale and descriptive analysis of specific health guidance: the nationwide lifestyle intervention program targeting metabolic syndrome in Japan. J. Atheroscler. Thromb. 25, 308–322 (2018)CrossRefPubMedPubMedCentral Tsushita, K., Hosler, A.S., Miura, K., Ito, Y., Fukuda, T., Kitamura, A., et al.: Rationale and descriptive analysis of specific health guidance: the nationwide lifestyle intervention program targeting metabolic syndrome in Japan. J. Atheroscler. Thromb. 25, 308–322 (2018)CrossRefPubMedPubMedCentral
go back to reference US Preventive Services Task Force, Curry, S.J., Krist, A.H., Owens, D.K., Barry, M.J., Caughey, A.B., et al.: Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US preventive services task force recommendation statement. JAMA 320, 1163–1171 (2018)CrossRef US Preventive Services Task Force, Curry, S.J., Krist, A.H., Owens, D.K., Barry, M.J., Caughey, A.B., et al.: Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US preventive services task force recommendation statement. JAMA 320, 1163–1171 (2018)CrossRef
go back to reference Xie, Y., Bowe, B., Gibson, A.K., McGill, J.B., Maddukuri, G., Yan, Y., Al-Aly, Z.: Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: Emulation of a target trial using health care databases. Diabetes Care 43, 2859–2869 (2020)CrossRefPubMed Xie, Y., Bowe, B., Gibson, A.K., McGill, J.B., Maddukuri, G., Yan, Y., Al-Aly, Z.: Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: Emulation of a target trial using health care databases. Diabetes Care 43, 2859–2869 (2020)CrossRefPubMed
Metadata
Title
Exact-matching algorithms using administrative health claims database equivalence factors for real-world data analysis based on the target trial emulation framework
Authors
Yuichi Nishioka
Emiri Morita
Saki Takeshita
Sakura Tamamoto
Tomoya Myojin
Tatsuya Noda
Tomoaki Imamura
Publication date
02-02-2024
Publisher
Springer US
Published in
Health Services and Outcomes Research Methodology
Print ISSN: 1387-3741
Electronic ISSN: 1572-9400
DOI
https://doi.org/10.1007/s10742-024-00322-9